Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B)

Tsubata, Yukari; Watanabe, Kana; Saito, Ryota; Nakamura, Atsushi; Yoshioka, Hiroshige; Morita, Mami; Honda, Ryoichi; Kanaji, Nobuhiro; Oizumi, Satoshi; Jingu, Daisuke; Nakagawa, Taku; Nakazawa, Kensuke; Mouri, Atsuto; Takeuchi, Susumu; Furuya, Naoki; Akazawa, Yuki; Miura, Kiyotaka; Ichihara, Eiki; Maemondo, Makoto; Morita, Satoshi; Kobayashi, Kunihiko; Isobe, Takeshi

doi:10.1007/s10147-022-02118-8

Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B)

Correction
Published: 08 March 2022

Volume 27, pages 823–824, (2022)
Cite this article

Download PDF

International Journal of Clinical Oncology Aims and scope Submit manuscript

Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B)

Download PDF

Yukari Tsubata ORCID: orcid.org/0000-0002-4260-2849¹,
Kana Watanabe²,
Ryota Saito³,
Atsushi Nakamura⁴,
Hiroshige Yoshioka⁵,
Mami Morita²,
Ryoichi Honda⁶,
Nobuhiro Kanaji⁷,
Satoshi Oizumi⁸,
Daisuke Jingu⁹,
Taku Nakagawa¹⁰,
Kensuke Nakazawa¹¹,
Atsuto Mouri¹²,
Susumu Takeuchi¹³,
Naoki Furuya¹⁴,
Yuki Akazawa¹⁵,
Kiyotaka Miura¹⁶,
Eiki Ichihara¹⁷,
Makoto Maemondo¹⁸,
Satoshi Morita¹⁹,
Kunihiko Kobayashi¹² &
…
Takeshi Isobe¹

1353 Accesses
Explore all metrics

The Original Article was published on 13 October 2021

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: International Journal of Clinical Oncology (2022) 27:112–120 https://doi.org/10.1007/s10147-021-02043-2

In the original publication, the name of ninth author was mistakenly published as: Satoshi Ohizumi. The correct name is: Satoshi Oizumi as given in this Correction.

Author information

Authors and Affiliations

Department of Internal Medicine, Division of Medical Oncology and Respiratory Medicine, Shimane University Faculty of Medicine, 89-1 Enya-cho, Izumo, Shimane, 693-8501, Japan
Yukari Tsubata & Takeshi Isobe
Department of Respiratory Medicine, Miyagi Cancer Center, 47-1, Nodayama, Medeshimashiote, Natori, Miyagi, 981-1293, Japan
Kana Watanabe & Mami Morita
Department of Respiratory Medicine, Tohoku University Hospital, 1-1, Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan
Ryota Saito
Department of Pulmonary Medicine, Sendai Kousei Hospital, 4-15, Hirose-machi, Aoba-ku, Sendai, Miyagi, 980-0873, Japan
Atsushi Nakamura
Department of Thoracic Oncology, Kansai Medical University Hospital, 2-3-1, Shin-machi, Hirakata, Osaka, 573-1191, Japan
Hiroshige Yoshioka
Department of Respiratory Medicine, Asahi General Hospital, Asahi, Chiba, 1326289-2511, Japan
Ryoichi Honda
Department of Internal Medicine, Division of Hematology, Rheumatology and Respiratory Medicine, Faculty of Medicine, Kagawa University, 1750-1, Ikenobe, Miki-cho, Kida-gun, Kagawa, 761-0793, Japan
Nobuhiro Kanaji
Department of Respiratory Medicine, National Hospital Organization Hokkaido Cancer Center, 2-3-54, 4-jyo, Kikusui, Shiraisi-ku, Sapporo, Hokkaido, 003-0804, Japan
Satoshi Oizumi
Department of Respiratory Medicine, Saka General Hospital, 16-5, Nishiki-cho, Shiogama, Miyagi, 985-8506, Japan
Daisuke Jingu
Department of Thoracic Surgery, Omagari Kosei Medical Center, 8-65, Toori-machi, Omagari, Daisen, Akita, 014-0027, Japan
Taku Nakagawa
Division of Clinical Medicine, Department of Pulmonary Medicine, Faculty of Medicine, University of Tsukuba, 2-1-1, Amakubo, Tsukuba, Ibaraki, 305-8576, Japan
Kensuke Nakazawa
Department of Respiratory Medicine, Saitama Medical University International Medical Center, 1397-1, Yamane, Hidaka, Saitama, 350-1298, Japan
Atsuto Mouri & Kunihiko Kobayashi
Division of General Thoracic and Thyroid Surgery, Tokyo Medical University, 6-7-1, Nishi-shinjuku, Shinjuku, Tokyo, 160-0023, Japan
Susumu Takeuchi
Division of Respiratory Medicine, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa, 216-8511, Japan
Naoki Furuya
Department of Thoracic Oncology, National Hospital Organization Osaka Toneyama Medical Center, 5-1-1, Toneyama, Toyonaka, Osaka, 560-8552, Japan
Yuki Akazawa
Department of Respiratory Medicine, Shimane Prefectural Central Hospital, 4-1-1, Himehara, Izumo, Shimane, 693-8555, Japan
Kiyotaka Miura
Department of Allergy and Respiratory Medicine, Okayama University Hospital, 2-5-1, Shikata-cho, Kita-ku, Okayama, 700-8558, Japan
Eiki Ichihara
Division of Pulmonary Medicine, Department of Internal Medicine, Iwate Medical University School of Medicine, 2-1-1, Idaidoori, Yahaba-cho, Shiwa-gun, Iwate, 028-3695, Japan
Makoto Maemondo
Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, 54, Shogoinkawahara-cho, Sakyo-ku, Kyoto, 606-8507, Japan
Satoshi Morita

Authors

Yukari Tsubata
View author publications
You can also search for this author in PubMed Google Scholar
Kana Watanabe
View author publications
You can also search for this author in PubMed Google Scholar
Ryota Saito
View author publications
You can also search for this author in PubMed Google Scholar
Atsushi Nakamura
View author publications
You can also search for this author in PubMed Google Scholar
Hiroshige Yoshioka
View author publications
You can also search for this author in PubMed Google Scholar
Mami Morita
View author publications
You can also search for this author in PubMed Google Scholar
Ryoichi Honda
View author publications
You can also search for this author in PubMed Google Scholar
Nobuhiro Kanaji
View author publications
You can also search for this author in PubMed Google Scholar
Satoshi Oizumi
View author publications
You can also search for this author in PubMed Google Scholar
Daisuke Jingu
View author publications
You can also search for this author in PubMed Google Scholar
Taku Nakagawa
View author publications
You can also search for this author in PubMed Google Scholar
Kensuke Nakazawa
View author publications
You can also search for this author in PubMed Google Scholar
Atsuto Mouri
View author publications
You can also search for this author in PubMed Google Scholar
Susumu Takeuchi
View author publications
You can also search for this author in PubMed Google Scholar
Naoki Furuya
View author publications
You can also search for this author in PubMed Google Scholar
Yuki Akazawa
View author publications
You can also search for this author in PubMed Google Scholar
Kiyotaka Miura
View author publications
You can also search for this author in PubMed Google Scholar
Eiki Ichihara
View author publications
You can also search for this author in PubMed Google Scholar
Makoto Maemondo
View author publications
You can also search for this author in PubMed Google Scholar
Satoshi Morita
View author publications
You can also search for this author in PubMed Google Scholar
Kunihiko Kobayashi
View author publications
You can also search for this author in PubMed Google Scholar
Takeshi Isobe
View author publications
You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yukari Tsubata.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

About this article

Cite this article

Tsubata, Y., Watanabe, K., Saito, R. et al. Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B). Int J Clin Oncol 27, 823–824 (2022). https://doi.org/10.1007/s10147-022-02118-8

Download citation

Published: 08 March 2022
Issue Date: April 2022
DOI: https://doi.org/10.1007/s10147-022-02118-8

Use our pre-submission checklist

Avoid common mistakes on your manuscript.

Correction to: Osimertinib in poor performance status patients with T790M‑positive advanced non‑small‑cell lung cancer after progression of first- and second‑generation EGFR‑TKI treatments (NEJ032B)

Correction to: International Journal of Clinical Oncology (2022) 27:112–120 https://doi.org/10.1007/s10147-021-02043-2

Author information

Authors and Affiliations

Corresponding author

Additional information

Publisher's Note

About this article

Cite this article

Share this article

Search

Navigation